Molecular Biology News and Research

RSS

Molecular biology is the study of biology at a molecular level. The field overlaps with other areas of biology and chemistry, particularly genetics and biochemistry. Molecular biology chiefly concerns itself with understanding the interactions between the various systems of a cell, including the interactions between DNA, RNA and protein biosynthesis as well as learning how these interactions are regulated.

Study on how cellular defence systems keep themselves in check from damaging cells themselves

When cells are attacked by bacteria they use all means at their disposal to defend themselves. But cellular defence systems can damage the cells themselves and so need to be kept tightly in check. Recent results help us to understand how this is done and give pointers to new ways of combating disease. Matthias Farlik in the group of Thomas Decker at the Centre for Molecular Biology of the University of Vienna (Max F. Perutz Laboratories) and Mathias Müller of the University of Veterinary Medicine, Vienna have published these findings in the current issue of the journal "Immunity".

16 Jul 2010

Studying retrovirus assembly can help new drug development for infection control

How a retrovirus, like HIV, reproduces and assembles new viruses is different than previously thought, according to Penn State College of Medicine researchers. Understanding the steps a virus takes for assembly could allow development of a way to prevent the spread of retroviral diseases. The team studied a chicken virus called Rous sarcoma virus that causes cancer in chickens and is similar to HIV.

16 Jul 2010

Spanish scientists develop new parasite detection method to prevent Anisakidosis

A new method enables anisakids to be detected in any fish product, from a whole fish, fresh or frozen, to tinned fish and surimi. Developed by Spanish scientists, the system is based on molecular techniques and overcomes the limitations of traditional procedures.

16 Jul 2010

NIH awards MacroGenics $9.8 million grant for three projects

MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million.

15 Jul 2010

Aduro BioTech announces issuance of two important patents

Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.

15 Jul 2010

Maven Semantic releases updates to Biotechnology research database

Maven Semantic (http://www.mavensemantic.com) announces updates to their Biotechnology research database.

14 Jul 2010

ZyGEM launches new microbial fingerprinting diagnostic technology

ZyGEM Corp. Ltd., has introduced its new microbial fingerprinting diagnostic technology that is expected to dramatically reduce the complexity and time needed to identify unknown infectious agents in mixed population samples. The approach is designed to run on the company's new MicroLab platform and has the potential to accurately identify up to 30 types of microbes simultaneously from a single sample in less than an hour.

14 Jul 2010

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.

14 Jul 2010

Insight into inner functional mechanisms of new bacterial infection target

In any battle, sizing up one's opponent is a critical first step. For researchers fighting a bacterial infection, that means assessing every nook and cranny of the malicious microorganism and identifying which ones to attack.

14 Jul 2010

Study suggests protein interferon therapy for individuals with asthma

An immune-system protein already used to treat diseases like multiple sclerosis, hepatitis C and a variety of cancers might also aid asthma patients, UT Southwestern Medical Center researchers have found.

14 Jul 2010

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

New England Biolabs has expanded its line of reagents for sample preparation with the introduction of NEBNext Quick DNA Sample Prep Reagent Set 2 and Master Mix Set 2, both suitable for library construction for Roche's 454 GS FLX Titanium and GS Junior instruments. These new products provide all the necessary enzymes and buffers for fast fragment library preparation.

From New England Biolabs 14 Jul 2010

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

EraGen Biosciences Inc., Madison, Wis., was congratulated today by SeqWright, Inc., Houston, on EraGen's successful FDA 510(k) market clearance of its MultiCode-RTx HSV 1 & 2 Kit. This new kit is the first FDA-cleared PCR-based qualitative in vitro diagnostic test for the detection and typing of HSV-1 and HSV-2 from vaginal lesion swab specimens in symptomatic female patients.

13 Jul 2010

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.

13 Jul 2010

CSHL scientists reverse symptoms of Type III SMA using ASOs

The devastating, currently incurable motor-neuron disease spinal muscular atrophy might soon be treated with tiny, chemically modified pieces of RNA called antisense oligonucleotides.

13 Jul 2010

Bayer HealthCare announces over $2.5M for largest awards program in hemophilia

Bayer HealthCare announced today that it awarded more than $2.5 million in funding to 19 recipients from 10 countries through its Bayer Hemophilia Awards Program (BHAP). BHAP is the largest awards program of its kind in hemophilia, providing funds that support clinical and basic research, encourage new physicians to enter the field and enable continuing education for caregivers around the world.

12 Jul 2010

British Mycological Society announces 'The Biology of Fungi' programme at IMC9

The British Mycological Society, in association with Elsevier, the world-leading publisher of scientific, technical and medical information, today announced the final programme for the 9th Mycological Congress IMC9: The Biology of Fungi. This congress takes place every 4 years at a different venue around the world.

12 Jul 2010

Pacific Biosciences launches PacBio DevNet at ISMB 2010

As part of its commitment to introducing third generation DNA sequencing technology to the market, Pacific Biosciences today announced the launch of a software developer's network - the PacBio DevNet - at the Eighteenth International Conference on Intelligent Systems for Molecular Biology (ISMB 2010).

9 Jul 2010

Research findings may help scientists understand how muscle and heart diseases develop

Researchers from Mount Sinai School of Medicine have identified a previously unknown mechanism by which cells direct gene expression, the process by which information from a gene is used to direct the physical and behavioral development of individuals. The research, which may help scientists gain insight into how muscle and heart diseases develop, is published in the July 8th issue of Nature.

9 Jul 2010

IRIC scientists identify vitamin B3 as potential antifungal treatment

A team of scientists from the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal have identified vitamin B3 as a potential antifungal treatment. Led by IRIC Principal Investigators Martine Raymond, Alain Verreault and Pierre Thibault, in collaboration with Alaka Mullick, from the Biotechnology Research Institute of the National Research Council Canada, the study is the subject of a recent article in Nature Medicine.

9 Jul 2010

Japanese scientists identify long-elusive enzyme necessary for proper regulation of cilia

It's safe to say that cilia, the hairlike appendages jutting out from the smooth surfaces of most mammalian cells, have long been misunderstood - underestimated, even.

8 Jul 2010

Molecular Biology News and Research

Further Reading

Study on how cellular defence systems keep themselves in check from damaging cells themselves

Studying retrovirus assembly can help new drug development for infection control

Spanish scientists develop new parasite detection method to prevent Anisakidosis

NIH awards MacroGenics $9.8 million grant for three projects

Aduro BioTech announces issuance of two important patents

Maven Semantic releases updates to Biotechnology research database

ZyGEM launches new microbial fingerprinting diagnostic technology

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

Insight into inner functional mechanisms of new bacterial infection target

Study suggests protein interferon therapy for individuals with asthma

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

CSHL scientists reverse symptoms of Type III SMA using ASOs

Bayer HealthCare announces over $2.5M for largest awards program in hemophilia

British Mycological Society announces 'The Biology of Fungi' programme at IMC9

Pacific Biosciences launches PacBio DevNet at ISMB 2010

Research findings may help scientists understand how muscle and heart diseases develop

IRIC scientists identify vitamin B3 as potential antifungal treatment

Japanese scientists identify long-elusive enzyme necessary for proper regulation of cilia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News